An insidious presentation of splenic marginal zone lymphoma

被引:2
作者
Burcheri, Sara
Arcaini, Luca
Della Porta, Mattec
Paulli, Marco
Boveri, Emanuela
Zibellini, Silvia
Rumi, Elisa
Algarotti, Alessandra
Passamouti, Francesco
Lazzarino, Mario
机构
[1] Univ Pavia, Policlin San Matteo, Fdn IRCCS, Div Hematol, I-27100 Pavia, Italy
[2] Univ Pavia, Policlin San Matteo, Fdn IRCCS, Dept Pathol, I-27100 Pavia, Italy
关键词
bone marrow; cytopenia; flow cytometry; histology; immunoglobulin H rearrangement; splenectomy;
D O I
10.3816/CLM.2007.n.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Herein, we report on a patient with splenic marginal zone lymphoma who initially presented without splenomegaly and bone marrow (BM) or peripheral blood involvement. At first, the patient showed moderate leukothrombocytopenia; she was completely asymptomatic, and BM examination excluded a hematologic disease. After 7 months, spleen enlargement was detected without determining any symptoms or worsening of the bilinear cytopenia. Bone marrow histologic, immunohistochemic, cytologic, and immunophenotypic examinations were normal. Splenectomy was performed, and a diagnosis of splenic marginal zone B-cell lymphoma was established. A monoclonal IgVH gene rearrangement was identified in the spleen tissue (VH3 gene family) and subsequently detected in the BM mononuclear cells. Because of the large surgical debulking and the absence of histologic, cytologic, and immunophenotypic BM involvement, no further treatment was proposed. After the splenectomy, the blood cell count normalized, and neither BM nor peripheral blood involvement appeared after 12 months of follow-up.
引用
收藏
页码:432 / 433
页数:2
相关论文
共 10 条
[1]   Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles [J].
Arcaini, L ;
Paulli, M ;
Boveri, E ;
Vallisa, D ;
Bernuzzi, P ;
Orlandi, E ;
Incardona, P ;
Brusamolino, E ;
Passamonti, F ;
Burcheri, S ;
Schena, C ;
Pascutto, C ;
Cavanna, L ;
Margrini, U ;
Lazzarino, M .
CANCER, 2004, 100 (01) :107-115
[2]  
Arcaini L, 2003, HAEMATOLOGICA, V88, P80
[3]   Splenic marginal zone lymphoma: a prognostic model for clinical use [J].
Arcaini, Luca ;
Lazzarino, Mario ;
Colombo, Nora ;
Burcheri, Sara ;
Boveri, Emanuela ;
Paulli, Marco ;
Morra, Enrica ;
Gambacorta, Marcello ;
Cortelazzo, Sergio ;
Tucci, Alessandra ;
Ungari, Marco ;
Ambrosetti, Achille ;
Menestrina, Fabio ;
Orsucci, Lorella ;
Novero, Domenico ;
Pulsoni, Alessandro ;
Frezzato, Maurizio ;
Gaidano, Gianluca ;
Vallisa, Daniele ;
Minardi, Viviana ;
Tripodo, Claudio ;
Callea, Vincenzo ;
Baldini, Luca ;
Merli, Francesco ;
Federico, Massimo ;
Franco, Vito ;
Iannitto, Emilio .
BLOOD, 2006, 107 (12) :4643-4649
[4]   Intrasinusoidal bone marrow infiltration: A possible hallmark of splenic lymphoma [J].
Franco, V ;
Florena, AM ;
Campesi, G .
HISTOPATHOLOGY, 1996, 29 (06) :571-575
[5]  
Franco V, 2001, CANCER-AM CANCER SOC, V91, P294, DOI 10.1002/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO
[6]  
2-W
[7]   Splenic marginal zone lymphoma with or without villous lymphocytes - Hematologic findings and outcomes in a series of 57 patients [J].
Iannitto, E ;
Ambrosetti, A ;
Ammatuna, E ;
Colosio, M ;
Florena, AM ;
Tripodo, C ;
Minardi, V ;
Calvaruso, G ;
Mitra, ME ;
Pizzolo, G ;
Menestrina, F ;
Franco, V .
CANCER, 2004, 101 (09) :2050-2057
[8]   The role of splenectomy in splenic marginal zone B-cell lymphoma [J].
Marti, GE .
CLINICAL LYMPHOMA, 2002, 3 (01) :48-48
[9]  
Thieblemont C, 2003, LANCET ONCOL, V4, P95, DOI 10.1016/S1470-2045(03)00981-1
[10]   Treatment of splenic marginal zone B-cell lymphoma: An analysis of 81 patients [J].
Thieblemont, C ;
Felman, P ;
Berger, F ;
Dumontet, C ;
Arnaud, P ;
Hequet, O ;
Arcache, J ;
Callet-Bauchu, E ;
Salles, G ;
Coiffier, B .
CLINICAL LYMPHOMA, 2002, 3 (01) :41-47